| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 5 |
| 1 | ADALIMUMAB-AATY | 4 |
| 2 | ADALIMUMAB-ADAZ | 4 |
| 3 | ADALIMUMAB-FKJP | 4 |
| 4 | ESTRADIOL | 4 |
| 5 | FINGOLIMOD HCL | 4 |
| 6 | ESTRADIOL GEL 0.1% | 3 |
| 7 | ESTRADIOL TRANSDERMAL | 3 |
| 8 | ESTRADIOL, | 3 |
| 9 | LEVETIRACETAM | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMYL NITRITE | 2 | 0.0333 |
| 1 | RALTEGRAVIR | 2 | 0.0004 |
| 2 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 2 | 0.0003 |
| 3 | LOPINAVIR AND RITONAVIR | 3 | 0.0002 |
| 4 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 2 | 0.0002 |
| 5 | DARUNAVIR 600 MG | 1 | 0.0002 |
| 6 | CABOTEGRAVIR AND RILPIVIRINE | 1 | 0.0002 |
| 7 | RILPIVIRINE | 1 | 0.0001 |
| 8 | CABOTEGRAVIR | 1 | 0.0001 |
| 9 | ADALIMUMAB-FKJP | 4 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytochrome P450 3A Inhibitor [EPC] | 6 | 0.0001 |
| 1 | Protease Inhibitor [EPC] | 4 | 0.0001 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0000 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Estrogen [EPC] | 4 | 0.0000 |
| 5 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |
| 6 | Central Nervous System Stimulant [EPC] | 1 | 0.0000 |
| 7 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |
| 8 | Interferon beta [EPC] | 1 | 0.0000 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 4 | 0.0000 |